Medications

Farxiga approved to reduce risk for CKD progression

(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.

Diseases, Conditions, Syndromes

She barely survived a severe form of COVID-19 hitting kids

Like many people this past year, teenager Tyona Montgomery began experiencing a sore throat and a loss of sense of smell and taste in November that suggested she might have COVID-19.

Health

Plant-based diets improve cardiac function, cognitive health

What if you could improve your heart health and brain function by changing your diet? Boston University School of Medicine researchers have found that by eating more plant-based food such as berries and green leafy vegetables ...

page 1 from 40